← Latest Filings
T

Turtle Cameron

Chief Executive Officer

Open-market buys
0
$0 total
Open-market sells
40
$11.4M total
Tracking since
Nov 2025
Activity timeline
Open-market sale — $9K
Spyre Therapeutics, Inc. · Oct 1, 2026
Open-market sale — $466K
Spyre Therapeutics, Inc. · Oct 1, 2026
Open-market trades from the last two years.

18 more trades. A free account shows you more; Premium shows every one.

Log in
Holdings as last reported
537,540 Common Stock in SYRE
Held directly · as of 2026-10-01
528,000 Stock Option (Right to Buy) in SYRE
Held directly · as of 2026-01-09

1 more holdings. A free account shows you more; Premium shows every one.

Log in
Companies touched
Spyre Therapeutics, Inc.
CIK 0001636282
Damora Therapeutics, Inc.
CIK 0001800315